Wellington Shields Capital Management’s West Pharmaceutical WST Stock Holding History

Wellington Shields Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$359K	Hold	1,000	–	–	0.05%	206
2026 Q1	$251K	Hold	1,000	–	–	0.04%	216
2025 Q4	$275K	Hold	1,000	–	–	0.04%	212
2025 Q3	$262K	Sell	1,000 -500	-33%	-$122K	0.04%	212
2025 Q2	$328K	Hold	1,500	–	–	0.06%	184
2025 Q1	$336K	Hold	1,500	–	–	0.06%	175
2024 Q4	$491K	Hold	1,500	–	–	0.09%	153
2024 Q3	$450K	Sell	1,500 -500	-25%	-$153K	0.08%	171
2024 Q2	$659K	Hold	2,000	–	–	0.12%	135
2024 Q1	$791K	Hold	2,000	–	–	0.15%	118
2023 Q4	$704K	Hold	2,000	–	–	0.09%	123
2023 Q3	$750K	Hold	2,000	–	–	0.1%	114
2023 Q2	$765K	Hold	2,000	–	–	0.09%	119
2023 Q1	$693K	Hold	2,000	–	–	0.08%	124
2022 Q4	$471K	Hold	2,000	–	–	0.06%	152
2022 Q3	$492K	Hold	2,000	–	–	0.12%	137
2022 Q2	$605K	Hold	2,000	–	–	0.08%	127
2022 Q1	$821K	Hold	2,000	–	–	0.09%	133
2021 Q4	$938K	Hold	2,000	–	–	0.12%	151
2021 Q3	$849K	Hold	2,000	–	–	0.12%	138
2021 Q2	$718K	Hold	2,000	–	–	0.09%	175
2021 Q1	$564K	Hold	2,000	–	–	0.05%	187
2020 Q4	$567K	Hold	2,000	–	–	0.08%	166
2020 Q3	$550K	Hold	2,000	–	–	0.09%	137
2020 Q2	$454K	Hold	2,000	–	–	0.07%	167
2020 Q1	$304K	Hold	2,000	–	–	0.06%	183
2019 Q4	$301K	Hold	2,000	–	–	0.05%	223
2019 Q3	$284K	Hold	2,000	–	–	0.05%	228
2019 Q2	$250K	Hold	2,000	–	–	0.04%	251
2019 Q1	$220K	Buy	+2,000	New	+$208K	0.04%	261

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Shields Capital Management's WST Position: Q2 2026 in Review

Wellington Shields Capital Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 1,000 shares worth $359K. The position accounts for 0.05% of the portfolio, ranked #206.

Wellington Shields Capital Management first reported a position in WST in Q1 2019 and has held it in 30 quarters since. The position peaked at $938K in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Wellington Shields Capital Management held 1,000 shares of West Pharmaceutical worth $359K as of Q2 2026.
Wellington Shields Capital Management left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.05% of Wellington Shields Capital Management's portfolio in Q2 2026, its #206 holding.
Wellington Shields Capital Management first reported a position in West Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
Wellington Shields Capital Management's West Pharmaceutical position peaked at $938K in Q4 2021.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.